ISPOR - PMU35 QUANTIFYING THE LOST MARKET SIZE OPPORTUNITY OF A TNF-INHIBITOR DUE TO DELAY IN TIME FROM PRIMARY TO SECONDARY INDICATION APPROVAL

PMU35 QUANTIFYING THE LOST MARKET SIZE OPPORTUNITY OF A TNF-INHIBITOR DUE TO DELAY IN TIME FROM PRIMARY TO SECONDARY INDICATION APPROVAL

Abstract

Authors

E. Thiel L. Palmer J. Robbins

Full Text Cite This Article

Back to Volume 22, Supplemental S3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now